Advertise On EU-Digest

Annual Advertising Rates
Showing posts with label Public. Show all posts
Showing posts with label Public. Show all posts

1/20/21

US News Media Poll: Most Voters Say News Media Have Too Much Influence Over Government

The latest Rasmussen Reports national telephone and online survey finds that 54% of Likely U.S. Voters say the news media have too much power and influence over government decisions, while 10% say the media don’t have enough power and 31% say the media have about the right amount of power.

Read more at: Most Voters Say News Media Have Too Much Influence Over Government - Rasmussen Reports®

11/9/17

The Netherlands: How to bring Government and the Public closer together to reach common achievable goals - by RM

The Dutch Ministry of Infrastructure and Environment, which apart from looking into all issues that have an interface with the environment, roads and waterways, also looks at innovative ideas, to provide solutions this ministry's diverse agenda requires.

The ministry argues that "if you do what you always did, you'll get what you always got." They say this is a valuable insight they use on a daily basis, because it makes things predictable and computable.

They call that experience.

But sometimes, they argue that experience also gets in their way. Especially if we ask for boundary solutions. As Einstein said: "We can not solve problems by using the same kind of thinking we used when we created them". 

If it really is different, if a breakthrough is really required, we ask people from all around the Netherlands to think "out-of-the-box".

A LEF Session in action
Out of the box?

And how do you do that, you might ask? Are people willing to say goodbye to their comfortable standards, values and thinking patterns? And are they able to cut new paths in their own brain with a surgical knife, so to speak ?

LEF helps to realize this concept. "Only when people really break their existing thinking patterns and frameworks,there is room for real innovation, for a real breakthrough they say. 

LEF Future Center is the organization within the Ministry of Infrastructure and Environment-specializing in the creation of breakthroughs and new patterns.

As to the practical side of how this LEF concept works, this came at the invitation of Erdal Sahin,, who invited me to attend one of these LEF sessions, at what the Ministry of Infrastructure and Environment calls the FUTURE CENTER, housed in the impressive modern Ministry building in Utrecht.
Dialog works: achieving common goals

The theme of this particular group discussion I attended, focused on "How to bring the Government and the Public closer together in reaching common achievable goals, eventually benefiting the community at-large".

The groups were divided in a variety of "psychological categories", which by itself is already quite an innovative approach, to get people thinking about similar issues, from different angles, based on their own interest and inner composure, but with the same ultimate goals in mind.

At the conclusion of this very interesting gathering of people, from a variety of disciplines, one could say that the overall opinion seemed to be that change will and can happen, mainly as a result of grass-roots movements, which start at the Public level, moving via the Municipal level, to eventually reach the Government level to make change happen.

It must also be noted that over the years the so-called "trickle-down" philosophy, whereby both the dialog and the economy are being directed to flow from the Government and/or the Corporate sector downwards, thereby benefiting the Public sector, has shown to be counter- productive and in many cases a total failure

With LEF obviously organizing many of these events throughout the year, one would hope the data of these dialogs are circulated and available, not only among government ministries, but also at municipalities, and educational institutions .    

Compliments to the Netherlands Ministry of Infrastructure and Environment, LEF and the organizers for putting this most stimulating event together.

EU-Digest

3/1/16

USA: Pharmaceutical Industry Ripoff of the Public Unacceptable:But Stephen J. Ubl Doesn't Buy iI

http://media.cagle.com/107/2012/08/14/116859_600.jpg
Big Pgharma is ripping us off
Few lobbyists have walked into the kind of political inferno that greeted Stephen J. Ubl when he became the top pitchman for the pharmaceutical industry.

Mr.n Ubl, the 47-year-old president and chief executive of the Pharmaceutical Research and Manufacturers of America, took charge in November, as the Obama administration, presidential candidates, members of Congress, consumer groups, health insurance companies and doctors were criticizing the prescription drug industry for charging prices they saw as exorbitant and excessive.

The anger has only grown worse.

“Enough is enough,” Senator Bernie Sanders of Vermont, the firebrand Democratic presidential candidate, wrote on Twitter on Thursday. “Pfizer and other pharmaceutical companies can no longer be allowed to rip off American patients.”

That anger is just one of the challenges facing Mr. Ubl.

The pharmaceutical and health products industry spent more on federal lobbying than any other industry in  2015, according to the Center for Responsive Politics, an independent group that tracks money in politics. 

Within that sector, the Pharmaceutical Research and Manufacturers of America led the list, with $18.4 million in spending on a wide range of health, trade and patent issues. Mr. Ubl’s lobbying powerhouse has members that include giants like Amgen, Eli Lilly, Johnson & ohnson, Merck and Pfizer.

Thegroup reported total expenses of nearly $208 million in 2014, the most recent available filing with the Internal Revenue Service. Its 170 employees work at its headquarters here, as well as in nine offices in the United States and others in Tokyo and Dubai.

Some of that money is used to cultivate strategic relationships through grants to doctor organizations and nonprofit advocacy groups representing patients with specific diseases like cancer, Alzheimer’s, diabetes and arthritis. And the organization multiplies its influence through more than 30 lobbying consultingc ommunications and law firms.

But public outrage over drug prices is boiling. John C. Rother, who leads the Campaign for Sustainable RPricing, backed by consumer, labor and physician groups, said Mr. Ubl was in an impossible position.

“The issue is prices,” Mr. Rother said, and the lobby for drug makers, like\ other trade associations, “can’t do much on prices without getting into trouble under the antitrust laws.” Any efforts to control or suggest
prices raise antitrust concerns, federal officials say.

Mr. Ubl (pronounced YOU-bul) said the drug lobby had been effective at beating back proposals like allowing the government to negotiate drug prices or import medicines from Canada. But, he said, it has not been as good at formulating and advancing a positive agenda. He hopes to change that. Brand-name drug companies and manufacturers of lower-cost generic drugs have historically been rivals. But Mr. Ubl said he wanted the government to speed the approval of generic drugs and approve more of them, reducing a backlog of generic drug applications. Increased competition, he said, would help hold down prices — and could perhaps avoid another outcry like the one over Daraprim, a drug to treat a life-threatening parasitic infection.

Turing Pharmaceuticals, a start-up founded by a former hedge fund manager, Martin Shkreli, acquired Daraprim last year and immediately increased the price to $750 a tablet, from $13.50.

Note EU-Digest: Many Americans who have family members or friends living abroad and need prescription drugs are often having them buy the exact similar prescription drugs as those being sold inAmerica, abroad,  at often less than 10% of the US listed price. 

In one particular case, a person who required eye drops to keep his Glaucoma pressure under control had a family friend buy the eye drops, which in America would have cost him $200.00   (same brand name and quality) for approximately $10.00 in Europe . This is not only scandalous, but also complete highway robbery.  

Read more: Pharmaceutical Industry Ripoff: Top Lobbyist for Drug Makers Threads a Thicket of Outrage -The New York Times